Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 11 Jun 2026 for BIOGEN INC..
Filing timeline
BuySaleWilliam A. Hawkins
Insider track record
Disclosed buys
2
Disclosed sells
0
Signal history
Closed purchases
Market purchases
2
Positive at T+90
100%
Median T+90
+18.6%
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +138.1%Entry US$2.91 · Close at T+365 US$6.93
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
William A. Hawkins: trading record in brief
Out of 33 filings, William A. Hawkins has just 2 open-market trades: two purchases at Bioventus Inc., one day apart, of EUR 110,056 on May 24, 2023 and EUR 109,134 on May 25, 2023, or EUR 219,190 together. No sale is recorded.
The title is Director at four US companies: Bioventus Inc. (10 filings), Biogen Inc. (8), Mimedx Group, Inc. (8) and Avanos Medical, Inc. (7). Published from January 6, 2016 to June 11, 2026, these filings include 23 share grants and 8 option exercises. The yearly volume stays low, with a maximum of 6 in 2023, while 2016 and 2017 have only one each. Two filings fall within the last twelve months, with neither purchase nor sale. The two purchases are the only open-market trades.
2 and 2 trades by Hawkins fall within 30 days of colleagues at Bioventus Inc., in that order. All in the same direction. Names in order: Anthony P. Bihl III and John A. Bartholdson.
Companies and markets linked to William A. Hawkins
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations33 total
1,505 sharesCommon StockSEC:0000875045-26-000065:0
39,789 shares0Class A Common StockSEC:0001106508-26-000003:0
28,609 shares@ US$6.4720.5% of flowCommon StockSEC:0001376339-25-000068:0
2,370 shares0Common StockSEC:0001127602-25-017762:0
26,493 shares0Class A Common StockSEC:0001578563-25-000304:0
1,340 shares0Common StockSEC:0001127602-24-019235:0
30,400 shares0Class A Common StockSEC:0001578563-24-000268:0
23,190 shares@ US$7.2619.7% of flowCommon StockSEC:0001376339-24-000046:0
960 shares0Common StockSEC:0001127602-23-019543:0
35,354 shares@ US$4.9520.7% of flowCommon StockSEC:0001376339-23-000038:0
16,648 shares0Class A Common StockSEC:0001578563-23-000038:0
44,000 shares@ US$2.6649.8% of flowClass A Common StockSEC:0001578563-23-000035:1
Canonical exit: 23 Aug 2023 (T+90)
44,000 shares@ US$2.6907100.0% of flowClass A Common StockSEC:0001578563-23-000035:0
Canonical exit: 22 Aug 2023 (T+90)
3,949 sharesClass A Common StockSEC:0000899243-23-008793:0
1,370 shares0Common StockSEC:0001127602-22-017781:0
44,191 shares@ US$3.9620.8% of flowCommon StockSEC:0001376339-22-000092:0
40,573 sharesClass A Common StockSEC:0000899243-22-013968:0
13,500 sharesClass A Common StockSEC:0000899243-22-006531:0
38,288 sharesClass A Common StockSEC:0000899243-22-006324:0
775 shares0Common StockSEC:0001127602-21-021332:0
17,056 shares@ US$10.2618.3% of flowCommon StockSEC:0001376339-21-000077:0
4,005 shares0Common StockSEC:0001606498-21-000003:0
15,964 shares@ US$7.839.3% of flowCommon StockSEC:0001376339-20-000155:0
26,236 shares@ US$6.6713.5% of flowCommon StockSEC:0001376339-20-000126:0
13,418 shares@ US$5.906.2% of flowCommon StockSEC:0001376339-20-000099:0
25 of 33 declarations
